VarmX, a biotech company focusing on the development of new approaches for the reversal of anticoagulation, has appointed Paul Roos as CFO. Roos, who has experience in the international life…
VarmX, a biotech company focusing on the development of new approaches for the reversal of anticoagulation, has appointed Paul Roos as CFO. Roos, who has experience in the international life…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


